2021 CERSI Innovations in Regulatory Science Summit

Sunday, January 10, 2021 - 8:00 am to 3:00 pm
Virtual Meeting - Times Shown are Pacific Time


The UCSF-Stanford Center of Excellence in Regulatory Science and Innovation (UCSF-Stanford CERSI) is pleased to present the second Innovations in Regulatory Science Summit, a gathering of leaders in the academia, industry and regulatory sectors to discuss the role of regulatory science in medical product development. This event will take place before the 2021 J.P. Morgan Healthcare Conference, and will comprise primarily of panel discussions and short science talks.


Panel Topics

  • Oncology
  • Infectious Disease
  • Pandemic Preparedness
  • Effects of COVID-19 on Medical Product Development

PDF iconDownload Poster


Registration is required, but free for all attendees.

Click Here to Register


Confirmed Speakers

Amy Abernethy (FDA)
Hal Barron (GlaxoSmithKline)
Diana Brenner (Gilead)
Brook Byers (Kleiner Perkins)
Robert Califf (Verily)
Jennifer Cochran (Stanford)
Joe Derisi (UCSF)
Martha Donoghue (FDA)
Laura Esserman (UCSF)
Kathy Giacomini (UCSF)
Sam Hawgood (UCSF)
Denise Hinton (FDA)
Peter Kim (Stanford)
Nevan Krogan (UCSF)
Mathai Mammen (Janssen)
Peter Marks (FDA)
Mark McClellan (Duke)
Andy Plump (Takeda)
George Scangos (Vir)
Jason Sello (UCSF)
Jeff Shuren (FDA)
Kuldev Singh (Stanford)
John Tsai (Novartis)
Leslie Wilson (UCSF)
Anne Wojcicki (23andMe)
Janet Woodcock (FDA)
George Yancopoulos (Regeneron)



The agenda will be posted here shortly.



Please contact [email protected] with any questions.